Invention Grant
US09125833B2 Multimodal abuse resistant and extended release opioid formulations
有权
多模式滥用抗性和延长释放阿片类药物
- Patent Title: Multimodal abuse resistant and extended release opioid formulations
- Patent Title (中): 多模式滥用抗性和延长释放阿片类药物
-
Application No.: US12597702Application Date: 2008-04-26
-
Publication No.: US09125833B2Publication Date: 2015-09-08
- Inventor: Najib Babul
- Applicant: Najib Babul
- Applicant Address: US PA Blue Bell
- Assignee: Relmada Therapeutics, Inc.
- Current Assignee: Relmada Therapeutics, Inc.
- Current Assignee Address: US PA Blue Bell
- Agency: Dilworth Paxson LLP
- Agent Gary D. Colby
- International Application: PCT/US2008/005541 WO 20080426
- International Announcement: WO2008/134071 WO 20081106
- Main IPC: A61K9/42
- IPC: A61K9/42 ; A61K31/44 ; A61K9/48 ; A61K9/20 ; A61K9/26
Abstract:
The present invention is in the field of oral, abuse resistant pharmaceutical compositions of opioid agonists, extended release pharmaceutical compositions of opioid agonists and extended release abuse resistant pharmaceutical compositions of opioid agonists and the use thereof. The present invention is also directed to extended release pharmaceutical compositions and the use thereof for preventing or minimizing the risk of abuse and/or toxicity from either intentional or unintentional tampering. The present invention is further directed at a method of preventing or minimizing the risk of abuse and/or toxicity from either intentional or unintentional tampering.
Public/Granted literature
- US20100249045A1 Multimodal Abuse Resistant and Extended Release Opioid Formulations Public/Granted day:2010-09-30
Information query
